HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Joseph R Duffy Selected Research

Apraxias (Dyspraxia)

9/2020Ioflupane 123I (DAT scan) SPECT identifies dopamine receptor dysfunction early in the disease course in progressive apraxia of speech.
1/2020Longitudinal flortaucipir ([18F]AV-1451) PET imaging in primary progressive apraxia of speech.
1/2018Disrupted functional connectivity in primary progressive apraxia of speech.
1/2016Clinical and MRI models predicting amyloid deposition in progressive aphasia and apraxia of speech.
11/2014APOE ε4 influences β-amyloid deposition in primary progressive aphasia and speech apraxia.
5/2010Fluorodeoxyglucose F18 positron emission tomography in progressive apraxia of speech and primary progressive aphasia variants.
12/2008Apraxia of speech and nonfluent aphasia: a new clinical marker for corticobasal degeneration and progressive supranuclear palsy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Joseph R Duffy Research Topics

Disease

9Primary Progressive Aphasia
12/2019 - 05/2010
7Progressive Supranuclear Palsy (Steele Richardson Olszewski Syndrome)
01/2022 - 06/2006
7Apraxias (Dyspraxia)
09/2020 - 12/2008
6Alzheimer Disease (Alzheimer's Disease)
12/2021 - 11/2014
6Corticobasal Degeneration
11/2020 - 06/2006
5Aphasia (Dysphasia)
01/2020 - 12/2013
4Frontotemporal Dementia (Semantic Dementia)
01/2021 - 01/2015
4Frontotemporal Lobar Degeneration (Degeneration, Frontotemporal Lobar)
01/2021 - 06/2006
4Tauopathies
11/2020 - 09/2015
3Dementia (Dementias)
01/2020 - 12/2008
2Atrophy
01/2021 - 01/2020
2Pick Disease of the Brain (Pick's Disease)
11/2020 - 06/2006
2Neurodegenerative Diseases (Neurodegenerative Disease)
01/2020 - 12/2008
2Tremor (Tremors)
11/2016 - 01/2014
2Language Disorders (Language Disorder)
11/2014 - 03/2014
1Cough
10/2021
1Dyskinesias (Dyskinesia)
10/2021
1Anomia (Dysnomia)
01/2021
1Disease Progression
01/2020
1Parkinsonian Disorders (Parkinsonism)
01/2020
1Essential Tremor (Essential Tremors)
11/2016
1Dysarthria (Spastic Dysarthria)
11/2016
1Pure Alexia
08/2014
1Dysphonia (Spastic Dysphonia)
01/2014
1Cognitive Dysfunction
12/2013
1Conversion Disorder (Astasia Abasia)
03/2012
1Gliosis
12/2008
1Broca Aphasia (Expressive Aphasia)
12/2008

Drug/Important Bio-Agent (IBA)

13Amyloid (Amyloid Fibrils)IBA
12/2021 - 12/2013
4Biomarkers (Surrogate Marker)IBA
01/2022 - 12/2008
4Apolipoproteins E (ApoE)IBA
12/2021 - 11/2014
47- (6- fluoropyridin- 3- yl)- 5H- pyrido(4,3- b)indoleIBA
11/2020 - 01/2020
42- (4'- (methylamino)phenyl)- 6- hydroxybenzothiazole (Pittsburgh compound B)IBA
01/2020 - 12/2013
3ApolipoproteinsIBA
12/2021 - 11/2014
3Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link
01/2021 - 05/2010
3Amyloid beta-PeptidesIBA
11/2018 - 01/2016
2Biological ProductsIBA
01/2020 - 01/2020
2Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA
01/2015 - 12/2008
2ProgranulinsIBA
01/2015 - 03/2014
1SynucleinsIBA
01/2021
12- carbomethoxy- 8- (3- fluoropropyl)- 3- (4- iodophenyl)tropaneIBA
09/2020
1ioflupaneIBA
09/2020
1Dopamine Receptors (Dopamine Receptor)IBA
09/2020
1Prostaglandins FIBA
01/2020
1Botulinum Toxins (Botulinum Toxin)IBA
01/2014
1Levodopa (L Dopa)FDA LinkGeneric
12/2008
1UbiquitinIBA
06/2006

Therapy/Procedure

2Therapeutics
10/2021 - 09/2015
1Language Therapy (Language Training)
10/2021
1Electrodes (Electrode)
11/2016
1Deep Brain Stimulation
11/2016
1Physical Therapy Modalities (Physical Therapy Technique)
03/2012
1Occupational Therapy (Therapy, Occupational)
03/2012